Pyxis Oncology
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $195M
Investors
- 21
About Pyxis Oncology
Based in Massachusetts, US, and founded in 2018 by co-founders David Steinberg, John L. Flavin, and Shaan Gandhi, Pyxis Oncology, Inc. is an immuno-oncology company with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor microenvironment. In March 2021, Pyxis Oncology, Inc. The company is listed on Nasdaq under the symbol PYXO. Pyxis Oncology, Inc. develops antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to improve the condition of cancer patients.'s revenue is generated from sales of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies. Pyxis Oncology, Inc. plans to further develop its differentiated portfolio of antibody-drug conjugates (ADC), both in-licensed from Pfizer and LegoChem Biosciences. The company will also continue advancing its immuno-oncology (I/O) pipeline to pursue a broad range of therapeutic indications.
Who invested in Pyxis Oncology
21 investors across 2 rounds
See all investors in Pyxis Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pyxis Oncology
Who invested in Pyxis Oncology?
Pyxis Oncology has 21 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pyxis Oncology raised?
Pyxis Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pyxis Oncology last raise money?
Pyxis Oncology's most recent round on record is a Series B, in Mar 2021.
What does Pyxis Oncology do?
Based in Massachusetts, US, and founded in 2018 by co-founders David Steinberg, John L.
Where is Pyxis Oncology headquartered?
Pyxis Oncology is headquartered in Cambridge, US.
Which VCs invest in companies like Pyxis Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pyxis Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pyxis Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.